Skip to content

Study of Genetics in Childhood Obesity

Defining the Etiology of Childhood Obesity Through DNA Exploration; a Study Investigating Clinical Application of Genetic Testing in Childhood Obesity

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07487584
Acronym
DECODE
Enrollment
500
Registered
2026-03-23
Start date
2026-06-01
Completion date
2027-09-01
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Childhood obesity is a major and growing health concern in the UK. Around 1 in 7 children aged 2-15 are living with obesity, which can lead to serious health problems and early death later in life. Some children develop obesity very early, before the age of 5. It is now recognised genes (the biological instructions that make up an individual) can play an important role alongside lifestyle and environment. Certain rare single-gene conditions ("monogenic obesity") can strongly influence a child's weight. The NHS already offers genetic testing for children with severe early-onset obesity, but it is not known how useful these tests are in everyday clinical practice. This study will help answer that question. The DECODE study will look back at information already collected from children aged 2-18 who attended specialist Complications of Excess Weight (CEW) clinics in England between 2021 and 2025. These clinics support children with severe obesity and related health problems. The study will include children whose obesity started before age 5 and who have already had one or both NHS genetic tests: the R149 obesity gene panel or a comparative genomic hybridisation (CGH) array (a test that looks for missing or extra pieces of DNA). The aim is to find out how often these tests detect a genetic cause of obesity ("diagnostic yield") and whether certain clinical features-such as developmental delay, neurodivergence, short stature or different eating behaviours -help predict a positive result. No new tests or visits are required for this study. Only anonymised information from medical records will be used. Around 500-800 children from up to ten hospitals are expected to be included. The findings will help the NHS understand who benefits most from genetic testing and how results can guide treatment, support families, and shape future services.

Interventions

None listed

Sponsors

Georgina Yan
Lead SponsorOTHER
Norfolk and Norwich University Hospitals NHS Foundation Trust
CollaboratorOTHER
Oxford University Hospitals NHS Trust
CollaboratorOTHER
Manchester University NHS Foundation Trust
CollaboratorOTHER_GOV
Birmingham Women's and Children's NHS Foundation Trust
CollaboratorOTHER
Bristol Royal Hospital for Children
CollaboratorOTHER
Frimley Park Hospital NHS Trust
CollaboratorOTHER
Dartford and Gravesham NHS Foundation Trust
CollaboratorUNKNOWN
Portsmouth Hospitals NHS Trust
CollaboratorOTHER_GOV
Nottingham University Hospitals NHS Trust
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Aged 2-18 years old * Early onset of obesity (before 5 years old) * Obesity (BMI SDS ≥3/ ≥99.6th percentile) * Attended a Complications of Excess Weight (CEW) clinic appointment between 2021 and 2025 (inclusive) and had a genetic investigation (R149 and/or CGH) array

Exclusion criteria

* Onset of obesity after 5 years of age * History of chemotherapy, radiotherapy, antipsychotics and steroid use (possible iatrogenic causes of obesity) * Known diagnosis of craniopharyngioma or hypothalamic tumour

Design outcomes

Primary

MeasureTime frame
Diagnostic yield of R149 and CGH array genetic testing in patients with severe, early-onset obesity under specialist paediatric weight management services2021-2025

Secondary

MeasureTime frame
The association of clinical features in the history with a positive genetic diagnosis namely: developmental delay, neurodivergence, learning difficulties, short stature, appetite dysregulation and restricted diet.2021-2025

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026